My colleague Chris Gacek recently released a new policy publication on the dangerous side effects of RU-486 (also known as Mifepristone). RU-486 is known as the abortion pill, and FRC has worked to analyze the side effects of this drug through reviewing the adverse event reports (AERs). Aside from the loss of the preborn child, there are many medical side effects that impact women.

According to a study on medical abortions safety and effectiveness, Obstetrics & Gynecology noted that:

Overall, medical abortion had roughly four times the rate of adverse events than surgical abortion did: 20.0% of women in the medical-abortion group and 5.6% of women in the surgical-abortion group had at least one type of adverse event. Hemorrhage, as an adverse event, was experienced by 15.6% of medical abortion patients compared with 2.1% for surgical patients. Incomplete abortions were experienced by 6.7% of medical abortion patients while only 1.6% of surgical patients had incomplete abortions. The rate for surgical (re)evacuation of the uterus was 5.9% (medical) versus 1.8% (surgical) for all causes (hemorrhage, infection, incomplete abortion).

RU-486, as well as, surgical abortions are dangerous not only to the child, but to the mother. To learn more about the dangers of RU-486, click here to read more of Chriss analysis.